Day: March 15, 2022

National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in Its Clinical Practice Guidelines in Oncology for B-cell Lymphomas

TRxADE HEALTH, INC. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. – 5:00 p.m. EDT

New H1 Solution Sets Out to Transform How Patients Discover, Evaluate and Engage Doctors, While Helping Payors Solve for Provider Data Inaccuracy

Powered by H1's expansive provider-centric knowledge base, H1 Precise systematically updates and manages provider data for directory accuracy and network...

error: Content is protected !!